Teva Branded Pharmaceutical Products R&D, Inc. clinical trials

A subsidiary of Teva Pharmaceutical Industries, Ltd.

The registry lists 228 studies whose lead sponsor is Teva Branded Pharmaceutical Products R&D, Inc.. 5 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 14, 2026.

Studies

Recruiting first, then most recently updated. Showing 50 of 228. List all 228 → · All Teva Pharmaceutical Industries, Ltd. studies →

• A Trial to Test the Safety and Efficacy of TEV-53408 in Participants With VitiligoRecruitingNCT06625177Phase 1

  Sponsor listed in the registry: Teva Branded Pharmaceutical Products R&D LLC

• An Extension Trial to Test if TEV-56286 is Effective in Relieving Multiple System AtrophyRecruitingNCT07197866Phase 2

  Sponsor listed in the registry: Teva Branded Pharmaceutical Products R&D LLC

• A Trial to Assess TEV-56286 at Different Doses in Healthy ParticipantsRecruitingNCT07674940Phase 1

  Sponsor listed in the registry: Teva Branded Pharmaceutical Products R&D LLC

• Fremanezumab Managed Access Program for Pediatric PatientsAvailableNCT03539393

  Sponsor listed in the registry: Teva Branded Pharmaceutical Products R&D LLC

• An Open-label Dose Escalation/Expansion Trial to Evaluate the Safety and Anti-tumor Activity of TEV-56278 Alone or in Combination With Pembrolizumab in Participants With Advanced or Metastatic Solid TumorsRecruitingNCT06480552Phase 1

  Sponsor listed in the registry: Teva Branded Pharmaceutical Products R&D LLC

• A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma ExacerbationsActive, not recruitingNCT06052267Phase 3

  Sponsor listed in the registry: Teva Branded Pharmaceutical Products R&D LLC

• A Trial to Assess the Efficacy and Safety of TEV-53408 in Adults With Celiac DiseaseActive, not recruitingNCT06807463Phase 2

  Sponsor listed in the registry: Teva Branded Pharmaceutical Products R&D LLC

• A Trial to Test if TEV-56286 is Effective for Treatment of Participants With Multiple System AtrophyActive, not recruitingNCT06568237Phase 2

  Sponsor listed in the registry: Teva Branded Pharmaceutical Products R&D LLC

• A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With AsthmaActive, not recruitingNCT06664619Phase 3

  Sponsor listed in the registry: Teva Branded Pharmaceutical Products R&D LLC

• A Study to Evaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's DiseaseActive, not recruitingNCT05668013Phase 2

  Sponsor listed in the registry: Teva Branded Pharmaceutical Products R&D LLC

• Real World Effectiveness and Safety of Deutetrabenazine in Adult Chinese Participants With Huntington's Disease (HD) Chorea in ChinaCompletedNCT07601516Phase 4

  Sponsor listed in the registry: Teva Branded Pharmaceutical Products R&D LLC

• Mass Balance Clinical Trial With TEV-56286CompletedNCT06627231Phase 1

  Sponsor listed in the registry: Teva Branded Pharmaceutical Products R&D, Inc.

• Pharmacokinetic Profile and Safety of Fluticasone Propionate and Albuterol Sulfate in Combination When Compared to Fluticasone Propionate Multidose Dry Powder Inhaler (Fp MDPI) in Children Aged 4 to 11 Years OldCompletedNCT06290102Phase 1

  Sponsor listed in the registry: Teva Branded Pharmaceutical Products R&D, Inc.

• A Trial to Test if Fremanezumab is Effective in Preventing Migraine in Children and AdolescentsCompletedNCT04530110Phase 3

  Sponsor listed in the registry: Teva Branded Pharmaceutical Products R&D LLC

• Safety, Tolerability, and Pharmacokinetic Study of TV-44749 in Chinese Patients With SchizophreniaCompletedNCT06253546Phase 1

  Sponsor listed in the registry: Teva Branded Pharmaceutical Products R&D LLC

• A Study to Test if Fremanezumab is Effective in Preventing Episodic Migraine in Patients 6 to 17 Years of AgeCompletedNCT04458857Phase 3

  Sponsor listed in the registry: Teva Branded Pharmaceutical Products R&D, Inc.

• A Study to Test the Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's DiseaseCompletedNCT05499130Phase 2

  Sponsor listed in the registry: Teva Branded Pharmaceutical Products R&D, Inc.

• A 12-Week Treatment Study to Evaluate the Effectiveness of Albuterol Multidose Dry Powder Inhaler With Integrated Electronic Module Digital System (eMDPI DS) in Participants13 Years or Older With AsthmaCompletedNCT03890666Phase 4

  Sponsor listed in the registry: Teva Branded Pharmaceutical Products R&D, Inc.

• A Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label, Long-Term Safety Phase to Evaluate the Efficacy and Safety of TV-44749 in Adults With SchizophreniaCompletedNCT05693935Phase 3

  Sponsor listed in the registry: Teva Branded Pharmaceutical Products R&D LLC

• A Study to Assess New Formulations of TEV-56286CompletedNCT06911567Phase 1

  Sponsor listed in the registry: Teva Branded Pharmaceutical Products R&D LLC

• A Study of Modakafusp Alfa Together With Daratumumab Adults With Relapsed or Refractory Multiple MyelomaTerminatedNCT05590377Phase 1/2

  Sponsor listed in the registry: Teva Branded Pharmaceutical Products R&D LLC

• A Study of Modakafusp Alfa on Adult Participants With Relapsed/Refractory Multiple MyelomaTerminatedNCT03215030Phase 1/2

  Sponsor listed in the registry: Teva Branded Pharmaceutical Products R&D LLC

• A Study of Modakafusp Alfa in Adult Participants With Multiple MyelomaTerminatedNCT05556616Phase 1

  Sponsor listed in the registry: Teva Branded Pharmaceutical Products R&D LLC

• A Study of Modakafusp Alfa (TAK-573) Given by Itself and Together With Pembrolizumab in Adults With Advanced or Metastatic Solid TumorsTerminatedNCT04157517Phase 1/2

  Sponsor listed in the registry: Teva Branded Pharmaceutical Products R&D LLC

• Open-label Trial Characterizing the PK of 3 SC Olanzapine Extended-release Formulations in Participants With Schizophrenia/Schizoaffective DisorderCompletedNCT06319170Phase 1

  Sponsor listed in the registry: Teva Branded Pharmaceutical Products R&D LLC

• A Study to Evaluate the Safety, Tolerability and Efficacy of Intravenous TAK-573 as Part of Combination Therapy in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)WithdrawnNCT04392648Phase 1

  Sponsor listed in the registry: Teva Branded Pharmaceutical Products R&D LLC

• An Open-Label Trial to Assess the Comparative Bioavailability of TV-44749 to Oral Olanzapine in Participants With SchizophreniaCompletedNCT06315283Phase 1

  Sponsor listed in the registry: Teva Branded Pharmaceutical Products R&D LLC

• A Study to Test if Fremanezumab is Effective in Preventing Chronic Migraine in Participants 6 to 17 Years of AgeCompletedNCT04464707Phase 3

  Sponsor listed in the registry: Teva Branded Pharmaceutical Products R&D, Inc.

• A Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label Period on Efficacy and Safety of Fremanezumab in Chinese Adults With MigraineCompletedNCT05458011Phase 3

  Sponsor listed in the registry: Teva Branded Pharmaceutical Products R&D, Inc.

• A Study to Test if TEV-50717 is Safe and Effective in Relieving Abnormal Involuntary Movements in Cerebral PalsyTerminatedNCT04200352Phase 3

  Sponsor listed in the registry: Teva Branded Pharmaceutical Products R&D, Inc.

• Balugrastim (Neugranin) in Breast Cancer Participants Receiving Doxorubicin/DocetaxelCompletedNCT00837265Phase 2/3

  Sponsor listed in the registry: Teva Branded Pharmaceutical Products R&D, Inc.

• Study to Evaluate the Mastery of Inhaler Technique for Budesonide Formoterol (BF) SPIROMAX® as Compared to SYMBICORT® TURBOHALER® as Treatment for Adult Participants With AsthmaCompletedNCT02062463Phase 3

  Sponsor listed in the registry: Teva Branded Pharmaceutical Products R&D, Inc.

• A Study to Evaluate the Pharmacokinetics (PK) of Medroxyprogesterone Acetate Following an Injection of TV-46046 in Healthy Women of Reproductive AgeCompletedNCT04682353Phase 1

  Sponsor listed in the registry: Teva Branded Pharmaceutical Products R&D, Inc.

• Study to Evaluate Suppression of Ovulation and Pharmacokinetics of Medroxyprogesterone Acetate Following Administration of TV-46046 in Women With Ovulatory CycleCompletedNCT02817464Phase 1

  Sponsor listed in the registry: Teva Branded Pharmaceutical Products R&D, Inc.

• Study to Determine the Maximum Tolerated Dose of the PARP Inhibitor CEP-9722 in Participants With Solid TumorsTerminatedNCT01311713Phase 1/2

  Sponsor listed in the registry: Teva Branded Pharmaceutical Products R&D, Inc.

• Efficacy and Safety Evaluation of Budesonide/Formoterol SPIROMAX® Inhalation Powder Versus SYMBICORT® TURBOHALER®CompletedNCT01803555Phase 3

  Sponsor listed in the registry: Teva Branded Pharmaceutical Products R&D, Inc.

• A Study to Evaluate the Efficacy and Safety of Fremanezumab for Preventive Treatment of Migraine in Patients With Major Depressive DisorderCompletedNCT04041284Phase 4

  Sponsor listed in the registry: Teva Branded Pharmaceutical Products R&D, Inc.

• A Study of TEV-50717 (Deutetrabenazine) for the Treatment of Dyskinesia in Cerebral Palsy in Children and AdolescentsCompletedNCT03813238Phase 3

  Sponsor listed in the registry: Teva Branded Pharmaceutical Products R&D, Inc.

• A Study of Pridopidine (ACR16) for the Treatment of Participants With Huntington's DiseaseCompletedNCT00724048Phase 2

  Sponsor listed in the registry: Teva Branded Pharmaceutical Products R&D, Inc.

• A Study of Treatment With Pridopidine (ACR16) in Participants With Huntington's DiseaseCompletedNCT00665223Phase 3

  Sponsor listed in the registry: Teva Branded Pharmaceutical Products R&D, Inc.

• Delanzomib (CEP-18770) in Combination With Lenalidomide and Dexamethasone in Relapsed or Refractory Multiple MyelomaCompletedNCT01348919Phase 1/2

  Sponsor listed in the registry: Teva Branded Pharmaceutical Products R&D, Inc.

• A Study to Test if TEV-53275 is Effective in Relieving AsthmaTerminatedNCT04847674Phase 2

  Sponsor listed in the registry: Teva Branded Pharmaceutical Products R&D, Inc.

• A Study of Bendamustine in the Treatment of Chinese Participants With Indolent Non-Hodgkin Lymphoma Refractory to Rituximab TreatmentCompletedNCT01596621Phase 3

  Sponsor listed in the registry: Teva Branded Pharmaceutical Products R&D, Inc.

• Bradykinesia Subscale Administered Alone Versus Regular Administration: Psychometric PropertiesCompletedNCT00932581

  Sponsor listed in the registry: Teva Branded Pharmaceutical Products R&D, Inc.

• A Study to Test the Effectiveness and Safety of Fremanezumab on Participants With FibromyalgiaTerminatedNCT03965091Phase 2

  Sponsor listed in the registry: Teva Branded Pharmaceutical Products R&D, Inc.

• Neugranin in Breast Cancer Participants Receiving Doxorubicin/DocetaxelCompletedNCT01126190Phase 3

  Sponsor listed in the registry: Teva Branded Pharmaceutical Products R&D, Inc.

• A 24-Week Treatment Study to Compare Standard of Care Versus the eMDPI DS in Participants 13 Years or Older With AsthmaCompletedNCT04677959Phase 4

  Sponsor listed in the registry: Teva Branded Pharmaceutical Products R&D, Inc.

• A Study to Test if TEV-48574 is Effective in Relieving AsthmaTerminatedNCT04545385Phase 2

  Sponsor listed in the registry: Teva Branded Pharmaceutical Products R&D, Inc.

• Study to Evaluate TV-46000 as Maintenance Treatment in Adult and Adolescent Participants With SchizophreniaCompletedNCT03503318Phase 3

  Sponsor listed in the registry: Teva Branded Pharmaceutical Products R&D, Inc.

• A Study of Reslizumab in Patients 12 Years of Age and Older With Severe Eosinophilic AsthmaTerminatedNCT03052725Phase 3

  Sponsor listed in the registry: Teva Branded Pharmaceutical Products R&D, Inc.